There are 2934 resources available
2782 - Efficacy evaluation of concurrent nivolumab addition to a first-line, concurrent chemo-radiotherapy regimen in unresectable locally advanced NSCLC – Results from the European Thoracic Oncology Platform (ETOP 6-14) NICOLAS phase II trial.
Presenter: Solange Peters
Session: Poster Discussion - Non-metastatic NSCLC and other thoracic malignancies
Resources:
Abstract
1634 - Phase III Study Comparing Second- and Third-Generation Regimens With Concurrent Thoracic Radiotherapy in Patients With Unresectable Stage III Non–Small-Cell Lung Cancer: 10-year follow-up of West Japan Thoracic Oncology Group WJTOG0105
Presenter: Yoshitaka Zenke
Session: Poster Discussion - Non-metastatic NSCLC and other thoracic malignancies
Resources:
Abstract
4480 - Efficacy of durvalumab in patients with Stage III NSCLC who experience pneumonitis (PACIFIC)
Presenter: Johan Vansteenkiste
Session: Poster Discussion - Non-metastatic NSCLC and other thoracic malignancies
Resources:
Abstract
1920 - Differential expression of B7-H4, VISTA, B7-H6, HHLA2, IDO-1, PD-L1 and CD8 in EGFR mutant and wild-type lung adenocarcinoma
Presenter: Shaorong Yu
Session: Poster Discussion - Non-metastatic NSCLC and other thoracic malignancies
Resources:
Abstract
3721 - Randomized phase II trial of CODE or AP after chemoradiotherapy for LD-SCLC: long-term survival and toxicity analysis
Presenter: Ikuo Sekine
Session: Poster Discussion - Non-metastatic NSCLC and other thoracic malignancies
Resources:
Abstract
5386 - Trilaciclib (T) decreases myelosuppression in extensive-stage small cell lung cancer (ES-SCLC) patients receiving 1st line chemotherapy plus atezolizumab
Presenter: Davey Daniel
Session: Poster Discussion - Non-metastatic NSCLC and other thoracic malignancies
Resources:
Abstract
Discussion led by Chair
Presenter: Javier Puente
Session: Specificity of upper tract urothelial carcinoma biology and management
Resources:
Slides
Webcast
Presentation of case/condition
Presenter: John Haanen
Session: Toxicity profiling of immunotherapy of cancer
Resources:
Slides
Webcast
Life-threatening immune toxicities
Presenter: Stephane Champiat
Session: Toxicity profiling of immunotherapy of cancer
Resources:
Slides
Webcast
Presentation of case/condition
Presenter: John Haanen
Session: Toxicity profiling of immunotherapy of cancer
Resources:
Slides
Webcast